Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea

NCT02257918 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

NIH

Sponsor class

Conditions

Gonorrhoea

Interventions

DRUG: AZD0914
DRUG: Ceftriaxone

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)